Male study dosing
2.4 mg targetShared trial protocol; not sex-specific
MGMT RESEARCHPRODUCT CONCEPT
RESEARCH COMPOUND
SEMARO Semaglutide 10 mg
SEMARO is our Semaglutide research compound, a selective GLP-1 receptor agonist. Available in 10 mg and 20 mg lyophilized vials for laboratory research.
$85.00 CADPer vial · 10 mg option
Shipping & Returns
Prices are in Canadian dollars and include tax. Shipping is calculated in your checkout order summary.
Delivery usually takes 3–7 days after dispatch, depending on your location. Allow up to 10 days for remote areas. Canada Post or FedEx is selected based on your mailing address.
Usual dispatch time
In-stock items usually ship the same day when payment is received before 12:00 p.m. EST. Some larger and wholesale orders ship the following day.
Check the product page for current availability, sourcing or preorder information before ordering. Dispatch timing is separate from the carrier’s delivery time.
No returns or refunds.
We do not accept returns or offer refunds, except where required by applicable law. Once our research compounds leave the warehouse, they cannot be returned to stock for resale.
This policy does not limit any rights or remedies required by applicable law.
Every compound vial includes one FREE 3 mL BAC Water and one compound / BAC pair holder. Any strength. No minimum purchase. Bundles count their included water toward this offer. Extra BAC Water is $10.00 CAD each.
Prices in CAD before tax. E-transfer accepted · Credit cards coming soon.
Includes FREE 3 mL BAC Water + a compound / BAC pair holder with every vial.
FORMATLyophilized powder
VIAL AMOUNT10 mg
INTENDED USELaboratory research
Female study dosing
2.4 mg targetShared trial protocol; not sex-specific
Frequency in trials
Once weeklySelected cited trial only
Route in trials
SubcutaneousInvestigational study material
Reported half-life
Approximately 1 weekPublished molecule/formulation; not this vial
Post-cycle PCT
Not establishedNo validated PCT protocol is provided
Study-reference information only. Any amounts, schedules, routes, or pharmacokinetic values describe the cited study material, not directions for using MGMT Research vials. Male and female labels do not imply separate recommendations. Target or maintenance study arms are not starting-dose instructions.
RESEARCH DESCRIPTION
SEMARO · Published research
Published clinical studies & evidence limits
STEP 1 investigated the underlying molecule in 1,961 adults with overweight or obesity without diabetes. At 68 weeks, mean body-weight change was −14.9% with the study formulation versus −2.4% with placebo; both groups received lifestyle intervention. Gastrointestinal adverse events occurred more often with active treatment. These results concern a defined clinical formulation and study population; they do not establish equivalent performance or suitability of SEMARO research material.
Molecular structure
SEMARO is a modified 31-residue GLP-1 analogue with amino acid substitutions and a C18 fatty diacid linked to a lysine residue.
Historical development
Discovery studies published in 2015 examined albumin binding and resistance to metabolic degradation.
Laboratory research applications
Laboratory applications include GLP-1 receptor signaling, receptor trafficking, protein association, aggregation, and chromatographic identity and stability studies.
Published findings describe the material and protocols used by the investigators. MGMT Research does not claim equivalent results for its products and does not recommend their use in humans or animals.
For laboratory research use only. Not for human or animal consumption, treatment, diagnosis, or prevention of disease.
Product specifications & handling +
- Product
- SEMARO · Semaglutide
- Selected quantity
- 10 mg
- Form
- Lyophilized powder
- Receptors
- GLP-1R
- Testing
- COA pending · laboratory not assigned
- Origin / dispatch
- Origin not confirmed / Toronto
Vial options: 10 mg / 20 mg. Intended use: Laboratory research only.
Supplier-provided storage guidance
This guidance applies to MGMT’s supplied peptide vials. Follow the actual product label and any batch-specific instructions.
Before reconstitution · lyophilized powder
Our supplier advises refrigeration at 2–8 °C for shorter-term storage and freezer storage when the powder will not be reconstituted soon. Confirm the freezer temperature in the product-specific storage instructions.
The supplier-stated estimates for lyophilized material are 12–18 months refrigerated and up to 24 months frozen. These are not independently verified stability results. Never exceed the expiry date on the label; receiving or freezing a vial does not restart its shelf life.
After reconstitution · prepared solution
For MGMT’s supplied formulations, our supplier advises keeping the prepared solution at 2–8 °C, protected from light, without freezing. This is product-specific guidance, not a rule for every peptide solution.
MGMT sets a maximum of three months after reconstitution. Follow any shorter limit specified by the product label, supplier, or validated laboratory procedure. This cap does not establish stability or microbiological suitability for three months.
If no preparation-specific storage period has been established, do not assume the solution can be kept for three months. The powder’s expiry does not establish a use-by date for the prepared solution.
In-stock items usually ship the same day when payment is received before 12:00 p.m. EST. Some larger and wholesale orders ship the following day. Coming-soon products are not available for dispatch.
COA pending. Purity and net-content results will be published when the batch-specific report is available.
MIX EASYYour mixture.
Your mixture.
Made clear.
Select your compound, vial amount, diluent volume, and sample amount. Our calculator converts your inputs into a concentration, volume, and U-100 syringe marking.
01
Set your mixture
mg
mL
Enter an example amount to calculate its volume.
02
Your measurement
SEMARO
20units
0.2 mL of solution per sample
U-100 scale1 mL = 100 units
Concentration10 mg/mL
Full samples per vial5
THE CALCULATION
2 mg ÷ 10 mg/mL = 0.2 mL
How to read this calculator +
Concentration = vial amount ÷ solution volume. Sample volume = sample amount ÷ concentration. U-100 scale units = volume in mL × 100; these are volume markings, not units of compound potency.
This example assumes the final solution volume equals the diluent volume entered, and that the compound dissolves completely. It does not establish solubility, compatibility, stability, or an administration dose.
Decimal measurements are mathematical results and may fall between markings. Full samples are rounded down; they do not account for handling losses.
The calculator checks concentration mathematics. It does not select a treatment dose or establish compatibility, sterility, or stability. BAC Water is the diluent, not a peptide.